期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 4, 期 6, 页码 551-555出版社
AMER CHEMICAL SOC
DOI: 10.1021/ml300427u
关键词
GPR40; full agonist; spirocycles; tricyclic; AM-5262; AM-1638; AMG 837; FFAR1; FFA1
GPR40 (FFAR1 or FFA1) is a target of high interest being pursued to treat type II diabetes due to its unique Mechanism leading to :little risk of hypoglycemia. We recently reported the discovery of AM-1638 (2), a potent full agonist. GPR40. In this report, we present the discovery Of GPR40 full agonists containing conformationally constrained tricyclic spirocycles and their structure- activity relationships leading to More potent agonists such as AM-5262 (26) with improved rat PK profile and general selectivity profile. AM-5262 enhanced glucose stimulated insulin secretion (mouse and human islets) and improved glucose homeostasis in vivo (OGTT in HF/STZ mice) when compared to AM-1638.,
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据